XGN
Exagen Incorporated Revolutionizes Autoimmune Disease Diagnosis with Unprecedented Momentum
On March 10th, Exagen Incorporated held its fourth-quarter earnings call for 2025, shedding light on the company's remarkable progress in revolutionizing autoimmune disease diagnosis. The conference call provided a glimpse into the company's vision to address the pressing issue of delayed and imprecise diagnoses in autoimmune